BioSpace News Archive

Drug Development

Xencor Doses First Patient in Phase 1 Study of XmAb®23104 for the Treatment of Patients with Advanced Solid Tumors

XmAb23104, a PD-1 x ICOS bispecific antibody, is the sixth XmAb® antibody engineered with Xencor’s bispecific Fc domain to enter clinical development

May 6, 2019
·
4 min read
BioCapital

HHMI Announces $30 Million Science Education Initiative

The grant program challenges colleges and universities to work with faculty to examine and change campus cultures so that a diverse group of students feel included in science

May 6, 2019
·
4 min read
FDA

Savara Announces Molgradex Received Fast Track Designation by FDA for Treatment of Autoimmune Pulmonary Alveolar Proteinosis

Topline results from the study are expected in June 2019.

May 6, 2019
·
5 min read
Drug Development

Initial Data for Alterity Therapeutics Phase 1 Clinical Trial Released at American Academy of Neurology Annual Meeting

The American Academy of Neurology Annual Meeting is one of the largest gatherings of clinicians and researchers focusing on neurology in the world.

May 6, 2019
·
3 min read
Genetown

Instrumentation Laboratory Worldwide Sales Top $1 Billion In 2018

Instrumentation Laboratory (IL) today announced total worldwide sales in 2018 of $1,047 M (€887 M), with total growth of 6.2% over 2017, in local currencies.

May 6, 2019
·
5 min read
Business

Velan Delivers Letter to the Board of Progenics Pharmaceuticals

Expresses Serious Concerns with the Company’s Persistent Underperformance and Destruction of Stockholder Value

May 6, 2019
·
8 min read
BioCapital

Medifast® Brings Healthy Habits to Underserved Communities with Lifestyle Brand OPTAVIA®

Medifast (NYSE: MED), a leading manufacturer and distributor of clinically proven programs and healthy living products, announces its commitment to bring healthy habits to kids and families in underserved communities.

May 6, 2019
·
3 min read
BioForest

Nass Valley Gateway Enters into Letter of Intent with CSB Supply BV to Supply CBD Products for Distribution under Nass Valley’s Brand

Nass Valley Gateway Ltd. (the “Company” or “Nass Valley”), trading on the Canadian Securities Exchange (“CSE”) under the trading Symbol “NVG” and on Deutsche Boerse Frankfurt under the trading Symbol 3NVN, is pleased to announce the signing of a letter of intent (“LOI”) with CSB Supply BV (“CSB”).

May 6, 2019
·
2 min read
Genetown

Anika to Participate in Two Investor Events in May 2019

- Deutsche Bank 44th Annual Health Care Conference on Tuesday, May 7, 2019 at The InterContinental Hotel in Boston. - Singular Research Spring Select Web Call on Thursday, May 30, 2019.

May 6, 2019
·
1 min read
Biotech Bay

Vytronus to Demonstrate Automated Ultrasound Technology in Clinical Development for the Treatment of Atrial Fibrillation

Vytronus, Inc., a privately held medical device company developing novel technologies for the treatment of cardiac arrhythmias, announced today that it will exhibit at the Heart Rhythm Society 2019 annual meeting being held this year in San Francisco from May 8–11.

May 6, 2019
·
2 min read